Yeji
PDUFAoutcome: unknownconf 0.98

exagamglogene autotemcel — PDUFA

$CRSP · CRISPR Therapeutics AG · severe sickle cell disease (SCD)
Event date
December 8, 2023
911 days ago
Sponsor runway
6+ yrs
$2.44B liquid

Evidence

The FDA has granted Priority Review for SCD and Standard Review for TDT and assigned Prescription Drug User Fee Act target action dates of December 8, 2023 and March 30, 2024, respectively.
Source: 8-K filed 2023-06-09View on EDGAR ↗0000950170-23-027129

Comparable historical pdufas· last 5 years · same event type

75% hit rate (3/4)
TickerDrugDateOutcome
$RCKTkresladi2026-03-28success
$RYTMimcivree2026-03-20success
$CYTKaficamten2025-12-26unknown
$ALDXreproxalap2025-12-16unknown
$BCRXorladeyo2025-12-12success
$OMERnarsoplimab2025-09-25unknown
$BCRXorladeyo (berotralstat)2025-09-12unknown
$ETONet-4002025-05-28unknown
$ALDXreproxalap2025-04-02failure
$IONSolezarsen2024-12-19unknown

Recent insider activity· ±90 days

5 insiders · 0 buys · 8 sells
Grant
2024-02-27
George Simeon
Director
216,578 @ $71.50$15.49M
Grant
2024-02-27
George Simeon
Director
63,177 @ $71.50$4.52M
Grant
2024-02-27
George Simeon
Director
769,196 @ $71.50$55.00M
Sell
2024-02-20
KASINGER JAMES R.
General Counsel and Secretary
1,913 @ $79.67$152K
Sell
2024-02-20
Kulkarni Samarth
Chief Executive Officer
6,370 @ $79.67$507K
Exercise
2024-02-18
Kulkarni Samarth
Chief Executive Officer
13,250 @
Exercise
2024-02-18
KASINGER JAMES R.
General Counsel and Secretary
3,825 @
Sell10b5-1
2024-02-15
Kulkarni Samarth
Chief Executive Officer
5,951 @ $81.04$482K
Sell10b5-1
2024-02-15
Kulkarni Samarth
Chief Executive Officer
1,100 @ $81.66$90K
Sell10b5-1
2024-02-15
Kulkarni Samarth
Chief Executive Officer
12,949 @ $79.94$1.04M
Exercise10b5-1
2024-02-15
Kulkarni Samarth
Chief Executive Officer
20,000 @ $19.12$382K
Exercise10b5-1
2024-01-29
Kulkarni Samarth
Chief Executive Officer
50,000 @ $19.12$956K
Sell10b5-1
2024-01-29
Kulkarni Samarth
Chief Executive Officer
700 @ $61.10$43K
Sell10b5-1
2024-01-29
Kulkarni Samarth
Chief Executive Officer
49,300 @ $60.50$2.98M
Exercise10b5-1
2024-01-16
Kulkarni Samarth
Chief Executive Officer
20,000 @ $19.12$382K
Sell10b5-1
2024-01-16
Kulkarni Samarth
Chief Executive Officer
20,000 @ $62.50$1.25M
Grant
2023-10-13
Kulkarni Samarth
Chief Executive Officer
25,000 @
Grant
2023-10-13
Prasad Raju
Chief Financial Officer
13,832 @
Grant
2023-10-13
KASINGER JAMES R.
General Counsel and Secretary
16,667 @
Grant
2023-10-13
KASINGER JAMES R.
General Counsel and Secretary
6,340 @
Grant
2023-10-13
Kulkarni Samarth
Chief Executive Officer
52,500 @
Grant
2023-10-13
Morrow Phuong Khanh
Chief Medical Officer
16,667 @